Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/21/2025

First-Line Prophylactic Treatment for Cluster Headache

Diagnosis Confirmation

  • The patient's presentation is consistent with cluster headache based on unilateral headache episodes lasting one hour, periorbital pain with autonomic symptoms, and normal neuroimaging ruling out secondary causes 1
  • Triggers for cluster headache include strong smells, such as tobacco, nail polish, or petroleum, which can exacerbate symptoms 2

Evidence-Based Treatment Algorithm

  • The VA/DoD guidelines recommend galcanezumab as the first-line prophylactic treatment for episodic cluster headache, with the strongest evidence among available prophylactic options 1, 3, 4
  • Galcanezumab has the strongest evidence among available prophylactic options for prevention of episodic cluster headache, according to the 2023 VA/DoD guidelines 5, 6
  • Oxygen therapy, specifically normobaric 100% oxygen, is recommended for acute treatment of cluster headache attacks, and should be administered at flow rates of at least 12 L/min for 15 minutes 1, 3, 4, 5
  • Subcutaneous sumatriptan or intranasal zolmitriptan are recommended for acute treatment of cluster headache attacks, providing rapid relief during an attack 1, 3, 4

Important Considerations

  • Monitoring requirements for galcanezumab include monitoring for injection site reactions and hypersensitivity 3
  • The American College of Cardiology and other guideline societies emphasize the importance of proper diagnosis and treatment of cluster headache to prevent misdiagnosis and ensure adequate treatment 2

First-Line Prophylactic Treatment for Cluster Headache

Evidence-Based Prophylactic Treatment Algorithm

  • The 2023 VA/DoD guidelines provide a weak recommendation FOR galcanezumab specifically for episodic cluster headache prevention, representing the strongest evidence among available prophylactic options for episodic cluster headache 7, 8
  • The 2023 VA/DoD guidelines state there is insufficient evidence to recommend for or against verapamil for episodic or chronic cluster headache prevention 7, 8
  • Galcanezumab is specifically recommended AGAINST for chronic cluster headache (weak recommendation against) 7, 8

Acute Treatment Considerations

  • Subcutaneous sumatriptan 6 mg or intranasal zolmitriptan 10 mg can be used for acute treatment while establishing prophylaxis 7, 8
  • 100% oxygen at 12 L/min for 15 minutes can be used for acute treatment 7, 8

Common Pitfalls to Avoid

  • Do not use galcanezumab if the patient progresses to chronic cluster headache (attacks >1 year without remission) 7, 8
  • Do not confuse acute and prophylactic treatments—oxygen and sumatriptan are for attacks, not prevention 7, 8